Analysts at Wells Fargo raised price targets for Medtronic, while UBS analysts provided bullish notes on the company's prospects.

The entities involved

• Medtronic plc →

  medical device company

  • Wolfe Research upgraded Medtronic's stock rating on July 4, 2025, coinciding with the company announcing the integration of the Affera platform.Sun 14:50
• Wells Fargo →

  American multinational banking and financial services company

  • Wells Fargo upgraded Sweetgreen stock to overweight from equal weight on September 28, 2026.Mon 16:33
  • Capital Research Global Investors acquired and increased its stake in Wells Fargo stock on June 19, 2026.Mon 16:28
• UBS →

  Swiss multinational investment bank and financial services company

  • The Trump administration threatens tariffs on Switzerland, leading Switzerland to seek a new trade agreement with the US.Mon 00:13
  • Following the acquisition of Credit Suisse, the Swiss parliament proposed new banking regulations for UBS.Sun 10:25

Related events

• Medtronic expands its Hugo system via investment and Jim Cramer views the company as a quandary stock.Sep 10
• Medtronic plc, Intuitive Surgical, Inc., and Abbott Laboratories are leaders in medical device technology and are currently facing market valuation pressures.Aug 28
• Analyst firms Mizuho, UBS, and Morgan Stanley raised price targets for Five Below on September 4, 2026.Sep 5
• Analyst cut price target due to pricing pressure for Carnival Corporation, involving Wells Fargo.Sep 15
• Corporate activity in the medical device sector in August 2025 included M&A activity (Stryker/Inari Medical, ZimVie/Archimed), competition between Medtronic and Intuitive Surgical, and the impact of Trump administration tariffs and FDA reviews.Jun 7